SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Estimating the opportunity costs of bed‐days
16 references·0 citing·41 second hop
Estimating the opportunity costs of bed‐days (2017)Estimating the opportunity costs of bed‐d…The Economics of Health and Health Care (2023)The Economics of Health and H…The Economics of Health and Health Care (2018)The Economics of Health and H…Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold (2015)Methods for the estimation of…Disability weights for the Global Burden of Disease 2013 study (2015)Disability weights for the Gl…Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold (2014)Updating Cost-Effectiveness —…Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force (2013)Consolidated Health Economic …Methods for the Economic Evaluation of Health Care Programmes (2005)Methods for the Economic Eval…UNCERTAINTY AND THE WELFARE ECONOMICS OF MEDICAL CARE (2003)UNCERTAINTY AND THE WELFARE E…The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies (1999)The irrelevance of inference:…Net Health Benefits (1998)Net Health BenefitsExternalities in Economies with Imperfect Information and Incomplete Markets (1986)Externalities in Economies wi…An Essay on the Nature and Significance of Economic Science (1984)An Essay on the Nature and Si…The economics of moral hazard: comment (1982)The economics of moral hazard…Cost and Choice: An Inquiry in Economic Theory (1979)Cost and Choice: An Inquiry i…The Economics of Moral Hazard (1969)The Economics of Moral HazardAn Inquiry into the Nature and Causes of the Wealth of Nations (1776)An Inquiry into the Nature an…Willingness to Pay for a Quality-adjusted Life Year (2000)Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold (2008)What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule? (2008)Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research (2016)Economics and mental health: the current scenario (2020)The Market for "Lemons": Quality Uncertainty and the Market Mechanism (1970)Job Market Signaling (1973)Credit Rationing in Markets with Imperfect Information (1981)Multitask Principal–Agent Analyses: Incentive Contracts, Asset Ownership, and Job Design (1991)Whom or What Does the Representative Individual Represent? (1992)Buzz: face-to-face contact and the urban economy (2004)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (2013)Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement (2016)Quantifying the burden of disease: the technical basis for disability-adjusted life years. (1994)Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 (2012)Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015)Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016)Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017)Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018)Increasing risk II: Its economic consequences (1971)The Analytics of Uncertainty and Information (1992)Representing uncertainty: the role of cost‐effectiveness acceptability curves (2001)American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options (2015)The estimation of a preference-based measure of health from the SF-36 (2002)Systematic reviews: CRD's guidance for undertaking reviews in health care (2010)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Clusters and knowledge: local buzz, global pipelines and the process of knowledge creation (2004)Finance and Growth: Theory and Evidence (2004)The building blocks of economic complexity (2009)Health insurance and the demand for medical care: evidence from a randomized experiment. (1987)The Theory of Incentives: The Principal-Agent Model (2001)Understanding and Mitigating Uncertainty in Online Exchange Relationships: A Principal–Agent Perspective1 (2007)On Economic Inequality (1973)What Can Economists Learn from Happiness Research? (2002)The Theory of Political Economy (2013)An Analysis of the Principal-Agent Problem (1983)An Analysis of the Principal-Agent Problem (1992)Chapter 11 The anatomy of health insurance (2000)
this work references cited by second hop

References

  • 1776An Inquiry into the Nature and Causes of the Wealth of Nations14,229 cited
  • 2005Methods for the Economic Evaluation of Health Care Programmes13,647 cited
  • 2003UNCERTAINTY AND THE WELFARE ECONOMICS OF MEDICAL CARE4,128 cited
  • 1984An Essay on the Nature and Significance of Economic Science3,259 cited
  • 2014Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold2,303 cited
  • 2013Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force2,025 cited
  • 1986Externalities in Economies with Imperfect Information and Incomplete Markets1,373 cited
  • 2015Disability weights for the Global Burden of Disease 2013 study1,246 cited
  • 1998Net Health Benefits1,104 cited
  • 1982The economics of moral hazard: comment987 cited
  • 1999The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies891 cited
  • 2015Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold857 cited
  • 2018The Economics of Health and Health Care608 cited
  • 1969The Economics of Moral Hazard573 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

1979
Cost and Choice: An Inquiry in Economic Theory
335 cited
  • 2023The Economics of Health and Health Care258 cited
  • Cited by

    No citing works inside the corpus for this window.